• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Dcal Share Price

    Dishman Carbogen Amcis Share PriceDishman Carbogen Amcis

    Small Cap 6.7k Result
    ₹163.2
    As on 04 December, 2023 | 01:56 BSE: 540701 NSE: DCALISIN: INE385W01011

    Dishman Carbogen Amcis Performance

    Day Range

    • Low 162.10
    • High 169.15
    ₹ 163.2

    52 Week Range

    • Low 80.00
    • High 179.20
    ₹ 163.2
    • Open Price164.05
    • Previous Close163.20
    • Volume461601

    Start SIP in Dishman Carbogen Amcis

    Start SIP

    Dishman Carbogen Amcis Share Price

    • Over 1 Month 12.63%
    • Over 3 Month 3.32%
    • Over 6 Month 35.44%
    • Over 1 Year 65.1%

    Dishman Carbogen Amcis Key Statistics

    P/E Ratio -53.7
    PEG Ratio 0.3
    Market Cap Cr 2,559
    Price to Book Ratio 0.4
    EPS -3.6
    Dividend 0
    Relative Strength Index 51.91
    Money Flow Index 69
    MACD Signal 3.47
    Average True Range 6.83

    Dishman Carbogen Amcis Investment Rating

    • Master Rating:

    • Dishman Carbogen Amcis has an operating revenue of Rs. 2,568.32 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of -2% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 15% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Dishman Carbogen Amcis Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 60701137810710483
    Operating Expenses Qtr Cr 63751078210510182
    Operating Profit Qtr Cr -3-56-3131
    Depreciation Qtr Cr 2525233353534
    Interest Qtr Cr 17181715141310
    Tax Qtr Cr -3-12-9-4-10-15-38
    Net Profit Qtr Cr -6-21-10-7-17-255
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 455369
    Operating Expenses Annual Cr 395269
    Operating Profit Annual in Cr 834
    Depreciation Cr 96140
    Interest Annual Cr 5837
    Tax Annual Cr -37-53
    Net Profit Annual Cr -59-32
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -53227
    Cash from Investing Activity Annual Cr 41-173
    Cash from Financing Annual Activity Cr 1-46
    Net Cash Flow Annual Cr -119
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 4,1144,232
    Fixed Assets Annual Cr 1,5251,474
    Total Non Current Assets Annual Cr 4,5314,449
    Total Current Assets Annual Cr 650766
    Total Assets Annual Cr 5,1815,214
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 262270
    ROE Annual % -1-1
    ROCE Annual % -1-1
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1533
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 587723619640614541569
    Operating Expenses Qtr Cr 526602567526535452547
    Operating Profit Qtr Cr 6112251114798822
    Depreciation Qtr Cr 75707650807584
    Interest Qtr Cr 27282422201916
    Tax Qtr Cr 512-17-1-2-4-41
    Net Profit Qtr Cr -4117-7147-104-45
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 2,4412,184
    Operating Expenses Annual Cr 2,0811,809
    Operating Profit Annual in Cr 332331
    Depreciation Cr 281308
    Interest Annual Cr 8657
    Tax Annual Cr -25-22
    Net Profit Annual Cr -3018
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 220355
    Cash from Investing Activity Annual Cr -448-619
    Cash from Financing Annual Activity Cr 250130
    Net Cash Flow Annual Cr 22-133
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 5,8105,549
    Fixed Assets Annual Cr 3,3672,907
    Total Non Current Assets Annual Cr 7,5356,799
    Total Current Assets Annual Cr 1,9181,839
    Total Assets Annual Cr 9,4548,637
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 371354
    ROE Annual % -10
    ROCE Annual % 11
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1518
    Invest in Dishman Carbogen Amcis

    Dishman Carbogen Amcis Technicals

    EMA & SMA

    Current Price
    ₹163.2
    0 (0%)
    pointer
    • Bullish Moving Average
    • ___
    • 10
    • Bearish Moving Average
    • ___
    • 6
    • 20 Day
    • ₹163.32
    • 50 Day
    • ₹159.33
    • 100 Day
    • ₹153.96
    • 200 Day
    • ₹144.91
    • 20 Day
    • ₹162.96
    • 50 Day
    • ₹158.91
    • 100 Day
    • ₹156.65
    • 200 Day
    • ₹141.66

    Dishman Carbogen Amcis Resistance and Support

    PIVOT
    ₹164.82
    Resistance
    First Resistance 167.53
    Second Resistance 171.87
    Third Resistance 174.58
    RSI 51.91
    MFI 69.00
    MACD Single Line 3.47
    MACD 3.16
    Support
    First Resistance 160.48
    Second Resistance 157.77
    Third Resistance 153.43

    Dishman Carbogen Amcis Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 492,245 17,248,265 35.04
    Week 368,458 15,265,225 41.43
    1 Month 822,385 32,204,613 39.16
    6 Month 968,401 34,571,918 35.7

    Dishman Carbogen Amcis Result Highlights

    Dishman Carbogen Amcis Synopsis

    NSE-Medical-Diversified

    Dishman Carbogen Amc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 402.55 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2023. Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338.
    Market Cap 2,559
    Sales 321
    Shares in Float 6.43
    No of funds 57
    Yield
    Book Value 0.62
    U/D Vol ratio 2
    LTDebt / Equity 4
    Alpha 0.19
    Beta 0.86

    Dishman Carbogen Amcis

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 59.32%59.32%59.32%59.32%
    Mutual Funds 3.28%2.9%2.32%3.63%
    Foreign Portfolio Investors 8.8%8.9%9.34%7.2%
    Individual Investors 24.64%24.57%24.62%25.65%
    Others 3.96%4.31%4.4%4.2%

    Dishman Carbogen Amcis Management

    Name Designation
    Mr. Janmejay R Vyas Chairman
    Mr. Arpit J Vyas Global Managing Director
    Mrs. Deohooti J Vyas Whole Time Director
    Mr. Sanjay S Majmudar Independent Director
    Mr. Ashok C Gandhi Independent Director
    Mr. Rajendra S Shah Independent Director
    Mr. Subir Kumar Das Independent Director
    Mr. Maitri K Mehta Director

    Dishman Carbogen Amcis Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Dishman Carbogen Amcis Corporate Action

    Date Purpose Remarks
    2023-11-08 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-23 Audited Results
    2023-02-10 Quarterly Results
    2023-01-17 Others Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement. per share(10%)Final Dividend

    Dishman Carbogen Amcis MF Shareholding

    Name Amount(cr)
    HSBC Flexi Cap Fund - Growth 3,504
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,271
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
    Groww Nifty Total Market Index Fund Regular Growth 32
    Motilal Oswal S&P BSE Healthcare ETF 8

    Dishman Carbogen Amcis FAQs

    What is Share Price of Dishman Carbogen Amcis ?

    Dishman Carbogen Amcis share price is ₹163 As on 04 December, 2023 | 01:42

    What is the Market Cap of Dishman Carbogen Amcis ?

    The Market Cap of Dishman Carbogen Amcis is ₹2558.7 Cr As on 04 December, 2023 | 01:42

    What is the P/E ratio of Dishman Carbogen Amcis ?

    The P/E ratio of Dishman Carbogen Amcis is -53.7 As on 04 December, 2023 | 01:42

    What is the PB ratio of Dishman Carbogen Amcis ?

    The PB ratio of Dishman Carbogen Amcis is 0.4 As on 04 December, 2023 | 01:42

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.